Abstract
Ten artemisinin derivatives containing a piperazine at C-10 linked with ether or ester were designed and synthesized. All the derivatives have improved antiproliferative activity against cancer cell lines, including multidrug resistance (MDR) phenotypes. Compounds linked with ether are more effective than compounds linked with ester.
Keywords: Artemisinin, Synthesis, Leukemia, Growth inhibition, Structure-activity relationship
Letters in Drug Design & Discovery
Title: Design, Synthesis and Antiproliferative Activities of Artemisinin Derivatives Containing a Substituted Piperazine
Volume: 6 Issue: 8
Author(s): Xue-Lin Yang, Dan Liu, Wei Wang, Lei Qu, Yong-Kui Jing and Lin-Xiang Zhao
Affiliation:
Keywords: Artemisinin, Synthesis, Leukemia, Growth inhibition, Structure-activity relationship
Abstract: Ten artemisinin derivatives containing a piperazine at C-10 linked with ether or ester were designed and synthesized. All the derivatives have improved antiproliferative activity against cancer cell lines, including multidrug resistance (MDR) phenotypes. Compounds linked with ether are more effective than compounds linked with ester.
Export Options
About this article
Cite this article as:
Yang Xue-Lin, Liu Dan, Wang Wei, Qu Lei, Jing Yong-Kui and Zhao Lin-Xiang, Design, Synthesis and Antiproliferative Activities of Artemisinin Derivatives Containing a Substituted Piperazine, Letters in Drug Design & Discovery 2009; 6 (8) . https://dx.doi.org/10.2174/157018009789353446
DOI https://dx.doi.org/10.2174/157018009789353446 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of ING Tumor Suppressors in UV Stress Response and Melanoma Progression
Current Drug Targets Dedication to Professor Tony Dodi
Current Cancer Therapy Reviews Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Current Drug Targets Transmembrane Phosphatases and Cancer Development, the Role of Protein Tyrosine Phosphatase-kappa (PTPκ) and Protein Tyrosine Phosphatase-mu (PTPμ)
Current Signal Transduction Therapy Small Non-Coding RNAs as Biomarkers
Recent Patents on Biomarkers Photosensitization of Biomolecules by Phenothiazine Derivatives
Current Drug Targets Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
Current Topics in Medicinal Chemistry Dual Topoisomerase I / II Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment
Current Pharmaceutical Design Mesenchymal Stromal Cells; Role in Tissue Repair, Drug Discovery and Immune Modulation
Current Drug Delivery Pathophysiology of Blood-Spinal Cord Barrier in Traumatic Injury and Repair
Current Pharmaceutical Design New and Under Explored Epigenetic Modulators in Search of New Paradigms
Medicinal Chemistry Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer
Current Drug Targets An Updated Review of Natural Products Intended to Prevent or Treat Oral Mucositis in Patients Undergoing Radio-Chemotherapy
Current Pharmaceutical Biotechnology Notch Signaling: A Potential Therapeutic Target in Prostate Cancer
Current Cancer Drug Targets Immunotherapy and Radiation Therapy in Renal Cell Carcinoma
Current Drug Targets The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
Current Medicinal Chemistry Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels
Current Diabetes Reviews Hybrid Viral Vectors for Vaccine and Antibody Production in Plants
Current Pharmaceutical Design Crocins: The Active Constituents of Crocus Sativus L. Stigmas, Exert Significant Cytotoxicity on Tumor Cells In Vitro
Current Cancer Therapy Reviews